Bulevirtide recently received conditional approval from the EMA for the treatment of chronic hepatitis delta, but the ideal duration of therapy is unknown. Herein, we describe the first case of hepatitis delta cure following 3 years of bulevirtide monotherapy in a patient with compensated cirrhosis and esophageal varices. During the 72-week off-bulevirtide follow-up, virological and biochemical responses were maintained. In the off-therapy liver biopsy, intrahepatic HDV RNA and hepatitis D antigen were undetectable, <1% of hepatocytes were hepatitis B surface antigen positive and all were negative for hepatitis B core antigen. Ishak grading and staging were improved following treatment
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics / M.P. Anolli, E. Degasperi, L. Allweiss, A. Sangiovanni, M. Maggioni, C. Scholtes, V. Oberhardt, C. Neumann-Haefelin, M. Dandri, F. Zoulim, P. Lampertico. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - 78:4(2023 Apr), pp. 876-880. [10.1016/j.jhep.2022.12.023]
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics
M.P. AnolliPrimo
;P. Lampertico
Ultimo
2023
Abstract
Bulevirtide recently received conditional approval from the EMA for the treatment of chronic hepatitis delta, but the ideal duration of therapy is unknown. Herein, we describe the first case of hepatitis delta cure following 3 years of bulevirtide monotherapy in a patient with compensated cirrhosis and esophageal varices. During the 72-week off-bulevirtide follow-up, virological and biochemical responses were maintained. In the off-therapy liver biopsy, intrahepatic HDV RNA and hepatitis D antigen were undetectable, <1% of hepatocytes were hepatitis B surface antigen positive and all were negative for hepatitis B core antigen. Ishak grading and staging were improved following treatmentFile | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S0168827822034754-main.pdf
accesso riservato
Descrizione: Case reports
Tipologia:
Publisher's version/PDF
Dimensione
677.04 kB
Formato
Adobe PDF
|
677.04 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.